physIQ and CellCarta think wearables and AI could produce vaccine insights

Originally published in MassDevice

physIQ announced today that it will collaborate with CellCarta to undertake a study using AI in vaccine development.

Enrollment is now complete in the VIII (Vaccine-induced inflammation investigation), which will monitor individual differences in physiologic changes associated with immune system activation in patients receiving vaccinations, including those developed to combat diseases like COVID-19.

Get the full story at our sister site, Drug Discovery & Development.